TOKYO - People in Japan who received Pfizer Inc.'s COVID-19 vaccine seem to have suffered anaphylaxis at a higher rate than in the United States and Europe, the minister in charge of vaccination efforts said Wednesday.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
